Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:ethyl ester
go back to main search page
Accession:CHEBI:23990 term browser browse the term
Definition:Any carboxylic ester resulting from the formal condensation of the carboxy group of a carboxylic acid with ethanol.
Synonyms:related_synonym: Formula=C3H5O2R;   SMILES=CCOC([*])=O;   carboxylic acid ethyl ester;   carboxylic acid ethyl esters;   ethyl carboxylate;   ethyl carboxylates;   ethyl esters
 alt_id: CHEBI:85056


show annotations for term's descendants           Sort by:
benazepril term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KNG1 kininogen 1 increases activity EXP benazepril results in increased activity of KNG1 protein modified form CTD PMID:7890486 NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958 		JBrowse link
clofibrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACO1 aconitase 1 increases expression EXP Clofibrate results in increased expression of ACO1 mRNA CTD PMID:17363680 NCBI chr10:33,937,833...34,001,895
Ensembl chr10:33,937,833...34,001,900 		JBrowse link
G ACOX1 acyl-CoA oxidase 1 increases expression EXP Clofibrate results in increased expression of ACOX1 mRNA CTD PMID:16896063 PMID:17437637 NCBI chr12:5,450,913...5,479,550
Ensembl chr12:5,439,361...5,479,546 		JBrowse link
G AGT angiotensinogen multiple interactions EXP Clofibrate inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein] CTD PMID:17105827 NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833 		JBrowse link
G ALB albumin decreases expression EXP Clofibrate results in decreased expression of ALB mRNA CTD PMID:16896063 NCBI chr 8:69,643,427...69,663,152
Ensembl chr 8:69,531,487...69,721,696 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases expression EXP Clofibrate results in increased expression of BAX mRNA CTD PMID:17437637 NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140 		JBrowse link
G BCL2L1 BCL2 like 1 decreases expression EXP Clofibrate results in decreased expression of BCL2L1 mRNA CTD PMID:17437637 NCBI chr17:35,366,139...35,415,798
Ensembl chr17:35,366,143...35,414,694 		JBrowse link
G CAT catalase increases expression EXP Clofibrate results in increased expression of CAT mRNA CTD PMID:17437637 NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452 		JBrowse link
G CPT1A carnitine palmitoyltransferase 1A increases expression EXP Clofibrate results in increased expression of CPT1A mRNA CTD PMID:16896063 PMID:17363680 NCBI chr 2:4,250,642...4,293,914
Ensembl chr 2:4,233,099...4,293,911 		JBrowse link
G CTSB cathepsin B increases expression EXP Clofibrate results in increased expression of CTSB mRNA CTD PMID:16896063 NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877 		JBrowse link
G DIO2 iodothyronine deiodinase 2 decreases expression EXP Clofibrate results in decreased expression of DIO2 mRNA CTD PMID:16896063 NCBI chr 7:103,096,414...103,110,749
Ensembl chr 7:103,096,433...103,323,258 		JBrowse link
G EDN1 endothelin 1 decreases expression
multiple interactions		 EXP Clofibrate results in decreased expression of EDN1 protein
Clofibrate inhibits the reaction [AGT protein modified form results in increased expression of EDN1 protein]; Clofibrate inhibits the reaction [KNG1 protein modified form results in increased expression of EDN1 protein]; Clofibrate inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EDN1 protein]; Nitric Oxide deficiency inhibits the reaction [Clofibrate results in decreased expression of EDN1 protein]		 CTD PMID:17105827 NCBI chr 7:8,752,018...8,758,354
Ensembl chr 7:8,751,695...8,758,348 		JBrowse link
G FABP1 fatty acid binding protein 1 increases expression EXP Clofibrate results in increased expression of FABP1 mRNA CTD PMID:17363680 NCBI chr 3:57,850,511...57,854,966
Ensembl chr 3:57,850,499...57,854,956 		JBrowse link
G GPX1 glutathione peroxidase 1 decreases expression EXP Clofibrate results in decreased expression of GPX1 mRNA CTD PMID:17437637 NCBI chr13:31,916,269...31,917,337
Ensembl chr13:31,916,246...31,917,433 		JBrowse link
G HMGCS2 3-hydroxy-3-methylglutaryl-CoA synthase 2 increases expression EXP Clofibrate results in increased expression of HMGCS2 mRNA CTD PMID:17363680 NCBI chr 4:101,420,941...101,440,302
Ensembl chr 4:101,420,872...101,438,126 		JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit increases expression EXP Clofibrate results in increased expression of JUN mRNA CTD PMID:17437637 NCBI chr 6:153,686,425...153,687,635
Ensembl chr 6:153,685,682...153,687,636 		JBrowse link
G KNG1 kininogen 1 multiple interactions EXP Clofibrate inhibits the reaction [KNG1 protein modified form results in increased expression of EDN1 protein] CTD PMID:17105827 NCBI chr13:124,521,276...124,557,384
Ensembl chr13:124,521,340...124,557,958 		JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor increases expression EXP Clofibrate results in increased expression of MYC mRNA CTD PMID:17437637 NCBI chr 4:12,455,141...12,460,360
Ensembl chr 4:12,455,122...12,461,078 		JBrowse link
G NOS3 nitric oxide synthase 3 increases expression
multiple interactions		 EXP Clofibrate results in increased expression of NOS3 protein
calphostin C inhibits the reaction [Clofibrate results in increased expression of NOS3 protein]		 CTD PMID:17105827 NCBI chr18:6,209,218...6,228,912
Ensembl chr18:6,209,158...6,228,943 		JBrowse link
G PPARA peroxisome proliferator activated receptor alpha increases expression
multiple interactions		 EXP Clofibrate results in increased expression of PPARA; Clofibrate results in increased expression of PPARA protein
calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA protein]; calphostin C inhibits the reaction [Clofibrate results in increased expression of PPARA]; Tetradecanoylphorbol Acetate inhibits the reaction [Clofibrate results in increased expression of PPARA]		 CTD PMID:17105827 PMID:20568414 NCBI chr 5:3,302,755...3,321,091
Ensembl chr 5:3,300,741...3,364,239 		JBrowse link
G SCD stearoyl-CoA desaturase increases expression EXP Clofibrate results in increased expression of SCD mRNA CTD PMID:17363680 NCBI chr14:111,461,560...111,478,033
Ensembl chr14:111,461,569...111,478,020 		JBrowse link
G SLC5A5 solute carrier family 5 member 5 increases expression EXP Clofibrate results in increased expression of SLC5A5 mRNA CTD PMID:16896063 NCBI chr 2:59,869,157...59,885,086
Ensembl chr 2:59,869,155...59,885,266 		JBrowse link
G SOD1 superoxide dismutase 1 increases expression EXP Clofibrate results in increased expression of SOD1 mRNA CTD PMID:17437637 NCBI chr13:195,326,573...195,335,273
Ensembl chr13:195,326,649...195,337,729 		JBrowse link
G THRA thyroid hormone receptor alpha decreases expression EXP Clofibrate results in decreased expression of THRA mRNA CTD PMID:16896063 NCBI chr12:22,270,506...22,296,684
Ensembl chr12:22,270,062...22,296,618 		JBrowse link
G TNF tumor necrosis factor decreases expression EXP Clofibrate results in decreased expression of TNF mRNA CTD PMID:17437637 NCBI chr 7:23,699,635...23,702,393
Ensembl chr 7:23,699,628...23,702,416 		JBrowse link
G TPO thyroid peroxidase increases expression EXP Clofibrate results in increased expression of TPO mRNA CTD PMID:16896063 NCBI chr 3:132,384,677...132,409,750
Ensembl chr 3:132,384,583...132,409,208 		JBrowse link
G TSHR thyroid stimulating hormone receptor increases expression EXP Clofibrate results in increased expression of TSHR mRNA CTD PMID:16896063 NCBI chr 7:103,768,260...103,925,777
Ensembl chr 7:103,768,296...103,925,922 		JBrowse link
G TTR transthyretin decreases expression EXP Clofibrate results in decreased expression of TTR mRNA CTD PMID:16896063 NCBI chr 6:115,496,338...115,503,974
Ensembl chr 6:115,496,326...115,503,977 		JBrowse link
diethyl maleate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PRDX2 peroxiredoxin 2 decreases activity EXP diethyl maleate results in decreased activity of PRDX2 protein CTD PMID:19208552 NCBI chr 2:66,207,829...66,211,474
Ensembl chr 2:66,207,828...66,212,009 		JBrowse link
malathion term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AKT2 AKT serine/threonine kinase 2 increases expression EXP Malathion results in increased expression of AKT2 mRNA CTD PMID:31535366 NCBI chr 6:48,555,785...48,620,472
Ensembl chr 6:48,555,795...48,587,919 		JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases expression EXP Malathion results in increased expression of BAX mRNA CTD PMID:31535366 NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,140 		JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression
multiple interactions		 EXP Malathion results in decreased expression of BCL2 mRNA
Melatonin inhibits the reaction [Malathion results in decreased expression of BCL2 mRNA]		 CTD PMID:31535366 NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879 		JBrowse link
G CAT catalase decreases expression
multiple interactions		 EXP Malathion results in decreased expression of CAT mRNA
Melatonin inhibits the reaction [Malathion results in decreased expression of CAT mRNA]		 CTD PMID:31535366 NCBI chr 2:26,493,664...26,533,881
Ensembl chr 2:26,487,653...26,581,452 		JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 decreases expression EXP Malathion results in decreased expression of CYP1A1 mRNA CTD PMID:31535366 NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775 		JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 decreases expression EXP Malathion results in decreased expression of CYP1B1 mRNA CTD PMID:31535366 NCBI chr 3:102,195,743...102,205,687
Ensembl chr 3:102,195,741...102,205,683 		JBrowse link
G DUOX2 dual oxidase 2 decreases expression EXP Malathion results in decreased expression of DUOX2 mRNA CTD PMID:31535366 NCBI chr 1:126,620,468...126,641,406
Ensembl chr 1:126,620,510...126,641,406 		JBrowse link
G GPX4 glutathione peroxidase 4 increases expression EXP Malathion results in increased expression of GPX4 mRNA CTD PMID:31535366 NCBI chr 2:77,321,568...77,323,931
Ensembl chr 2:77,320,464...77,323,931 		JBrowse link
G GPX6 glutathione peroxidase 6 increases expression EXP Malathion results in increased expression of GPX6 mRNA CTD PMID:31535366 NCBI chr 7:22,256,013...22,267,992
Ensembl chr 7:22,256,038...22,267,992 		JBrowse link
G LOC106504562 glutathione S-transferase alpha M14 decreases expression EXP Malathion results in decreased expression of GSTA1 mRNA CTD PMID:31535366 NCBI chr 7:46,553,813...46,567,596 JBrowse link
G MT-CO1 mitochondrially encoded cytochrome c oxidase I affects expression EXP Malathion affects the expression of COX1 mRNA CTD PMID:17454254 NCBI chr MT:6,511...8,055
Ensembl chr MT:6,511...8,055 		JBrowse link
G MT-CO3 mitochondrially encoded cytochrome c oxidase III affects expression EXP Malathion affects the expression of COX3 mRNA CTD PMID:17454254 NCBI chr MT:9,800...10,583
Ensembl chr MT:9,800...10,583 		JBrowse link
G PLIN2 perilipin 2 multiple interactions
decreases expression		 EXP Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PLIN2 protein]
Malathion results in decreased expression of PLIN2 mRNA; Malathion results in decreased expression of PLIN2 protein		 CTD PMID:31535366 NCBI chr 1:203,683,867...203,709,277
Ensembl chr 1:203,683,862...203,709,273 		JBrowse link
G PPARG peroxisome proliferator activated receptor gamma multiple interactions
decreases expression		 EXP Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG mRNA]; Melatonin inhibits the reaction [Malathion results in decreased expression of PPARG protein]
Malathion results in decreased expression of PPARG mRNA; Malathion results in decreased expression of PPARG protein		 CTD PMID:31535366 NCBI chr13:68,301,566...68,433,951
Ensembl chr13:68,302,322...68,433,944 		JBrowse link
G SLC34A2 solute carrier family 34 member 2 increases expression EXP Malathion results in increased expression of SLC34A2 mRNA CTD PMID:31535366 NCBI chr 8:19,481,127...19,507,903
Ensembl chr 8:19,481,198...19,509,666 		JBrowse link
G SOD2 superoxide dismutase 2 increases expression EXP Malathion results in increased expression of SOD2 mRNA CTD PMID:31535366 NCBI chr 1:7,679,352...7,689,564
Ensembl chr 1:7,679,352...7,689,560 		JBrowse link
G SORD sorbitol dehydrogenase increases expression EXP Malathion results in increased expression of SORD mRNA CTD PMID:31535366 NCBI chr 1:126,659,198...126,701,084
Ensembl chr 1:126,655,156...126,701,138 		JBrowse link
G TP53 tumor protein p53 increases expression
multiple interactions		 EXP Malathion results in increased expression of TP53 mRNA
Melatonin inhibits the reaction [Malathion results in increased expression of TP53 mRNA]		 CTD PMID:31535366 NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 5177
    role 5144
      biological role 5144
        antimicrobial agent 286
          disinfectant 141
            ethanol 99
              ethyl ester 44
                (+)-jasplakinolide Z3 0
                (5,12,13-Triaza-indeno[1,2-b]anthracen-13-yl)-acetic acid ethylester 0
                (R)-mefenpyr-diethyl + 0
                (S)-mefenpyr-diethyl + 0
                3,5-diethoxycarbonyl-1,4-dihydrocollidine 0
                3-(ethoxycarbonyl)psoralen 0
                3-[(1S,2S,6S)-2-\{2-[(1S,2R,3R)-2-(3-ethoxy-3-oxopropyl)-3-(2-hydroxypropan-2-yl)-2-methyl-6-methylidenecyclohexyl]ethyl\}-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid 0
                4-[dimethylamino(oxo)methyl]-3,5-dimethyl-1H-pyrrole-2-carboxylic acid ethyl ester 0
                5-[[3-(1,5-dimethyl-4-pyrazolyl)-1-oxoprop-2-enyl]amino]-3-methylthiophene-2,4-dicarboxylic acid O2-ethyl ester O4-propan-2-yl ester 0
                6-O-(carboxymethyl)fluorescein ethyl ester 0
                6-carboxyrhodamine 6G 0
                ATTO 425-2 + 0
                ATTO 425-3 0
                ATTO 425-4 0
                ATTO 425-7 0
                CAY10397 0
                Ethyl 3-(N-butylacetamido)propionate 0
                Ethyl cinnamate 0
                JTE-607 free base 0
                N-(tert-butoxycarbonyl)-L-seryl-L-valyl-N-\{(2S,3E)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl\}-L-leucinamide 0
                NMDI14 0
                PYR-41 + 0
                SG85 0
                SRS11-92 0
                alanycarb 0
                aloxistatin 0
                alpha-methyl-L-dopa ethyl ester 0
                amlodipine + 0
                anileridine 0
                benazepril 1
                benazolin-ethyl 0
                benfuracarb 0
                chlorimuron-ethyl 0
                cilazapril + 0
                cinidon ethyl 0
                clofibrate 27
                coumarin 504 0
                diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate + 18
                diethyl 2-[(dimethoxyphosphoryl)thio]succinate + 0
                diethyl 2-methyl-3-hydroxysuccinate + 0
                diethyl 2-methyl-3-oxosuccinate 0
                diethyl 2-sulfanylbutanedioate + 18
                diethyl maleate 1
                diethyl phthalate 0
                diphenoxylate + 0
                epyrifenacil 0
                erythromycin ethylsuccinate 0
                etazolate 0
                ethyl (2E,4S)-4-[((2R)-2-\{[N-(tert-butoxycarbonyl)-L-valyl]amino\}-2-phenylethanoyl)amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate 0
                ethyl (4R)-4-[((2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-\{[(5-methylisoxazol-3-yl)carbonyl]amino\}-4-oxoheptanoyl)amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate 0
                ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate 0
                ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate + 0
                ethyl 2-(methylamino)-1-phenylcyclohex-3-ene-1-carboxylate + 0
                ethyl 2-[4-(2H-1,4-benzothiazin-3-yl)piperazin-1-yl]-1,3-thiazole-4-carboxylate 0
                ethyl 2-[5-benzyloxy-4'-(trifluoromethyl)biphenyl-3-yl]pentanoate 0
                ethyl 2-[5-hydroxy-4'-(trifluoromethyl)biphenyl-3-yl]pentanoate 0
                ethyl 2-\{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy\}propanoate + 0
                ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate 0
                ethyl 2-chloro-3-\{2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-4-fluorophenyl\}propanoate + 0
                ethyl 2-cyanoacetoacetate 0
                ethyl 2-cyanopropionate 0
                ethyl 2-hydroxy-5-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate + 0
                ethyl 2-hydroxypropanoate + 0
                ethyl 3,4-dihydroxybenzoate 0
                ethyl 3-(2-furyl)acrylate + 0
                ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate + 0
                ethyl 3-phenyl-2-\{[4-(toluene-4-sulfonyl)thiomorpholine-3-carbonyl]amino\}propionate 0
                ethyl 4-(3-hydroxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate + 0
                ethyl 4-(3-methoxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate 0
                ethyl 4-hydroxybenzoate sulfate 0
                ethyl 4-oxocyclohexanecarboxylate 0
                ethyl L-phenylalaninate 0
                ethyl L-tyrosinate 0
                ethyl N-acetyl-L-tyrosinate 0
                ethyl N-acetylneuraminate 0
                ethyl N-benzoyl-L-tyrosinate 0
                ethyl [5-benzyloxy-4'-(trifluoromethyl)biphenyl-3-yl]acetate 0
                ethyl acetate 0
                ethyl acetoacetate 0
                ethyl benzoate 0
                ethyl cyclohexanecarboxylate 0
                ethyl formate 0
                ethyl glyoxylate 0
                ethyl hydroxy(phenyl)acetate + 0
                ethyl lansiolate 0
                ethyl phenylcyanoacetate 0
                ethyl phenylglyoxylate 0
                ethyl propiolate 0
                ethyl trans-caffeate 0
                ethylparaben 0
                etomidate 0
                etretinate 0
                fatty acid ethyl ester + 0
                felodipine 0
                ferrostatin-1 + 0
                flufenpyr-ethyl 0
                flumazenil 0
                hydroprene + 0
                imidapril + 0
                isoxadifen-ethyl 0
                lansic acid 3-ethyl ester 0
                loratadine 0
                molsidomine 0
                monoethyl phthalate 0
                nemadipine-A 0
                nitrendipine 0
                parbenate 0
                perindopril 0
                pethidine 0
                phenthoate 0
                pyraflufen-ethyl 0
                pyrazophos 0
                quinapril 0
                ramipril 0
                spirapril 0
                tazarotene 0
                tensyuic acid C 0
                tensyuic acid F 0
                trandolapril 0
                triazamate 0
                trinexapac-ethyl 0
                ximelagatran 0
                ximelagatran (hydroxylamine form) 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 5177
    subatomic particle 5168
      composite particle 5168
        hadron 5168
          baryon 5168
            nucleon 5168
              atomic nucleus 5168
                atom 5168
                  main group element atom 5140
                    p-block element atom 5137
                      chalcogen 5035
                        oxygen atom 5003
                          oxygen molecular entity 5003
                            hydroxides 4956
                              organic hydroxy compound 4886
                                alcohol 4517
                                  primary alcohol 4487
                                    ethanols 99
                                      ethanol 99
                                        ethyl ester 44
                                          (+)-jasplakinolide Z3 0
                                          (5,12,13-Triaza-indeno[1,2-b]anthracen-13-yl)-acetic acid ethylester 0
                                          (R)-mefenpyr-diethyl + 0
                                          (S)-mefenpyr-diethyl + 0
                                          3,5-diethoxycarbonyl-1,4-dihydrocollidine 0
                                          3-(ethoxycarbonyl)psoralen 0
                                          3-[(1S,2S,6S)-2-\{2-[(1S,2R,3R)-2-(3-ethoxy-3-oxopropyl)-3-(2-hydroxypropan-2-yl)-2-methyl-6-methylidenecyclohexyl]ethyl\}-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid 0
                                          4-[dimethylamino(oxo)methyl]-3,5-dimethyl-1H-pyrrole-2-carboxylic acid ethyl ester 0
                                          5-[[3-(1,5-dimethyl-4-pyrazolyl)-1-oxoprop-2-enyl]amino]-3-methylthiophene-2,4-dicarboxylic acid O2-ethyl ester O4-propan-2-yl ester 0
                                          6-O-(carboxymethyl)fluorescein ethyl ester 0
                                          6-carboxyrhodamine 6G 0
                                          ATTO 425-2 + 0
                                          ATTO 425-3 0
                                          ATTO 425-4 0
                                          ATTO 425-7 0
                                          CAY10397 0
                                          Ethyl 3-(N-butylacetamido)propionate 0
                                          Ethyl cinnamate 0
                                          JTE-607 free base 0
                                          N-(tert-butoxycarbonyl)-L-seryl-L-valyl-N-\{(2S,3E)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pent-3-en-2-yl\}-L-leucinamide 0
                                          NMDI14 0
                                          PYR-41 + 0
                                          SG85 0
                                          SRS11-92 0
                                          alanycarb 0
                                          aloxistatin 0
                                          alpha-methyl-L-dopa ethyl ester 0
                                          amlodipine + 0
                                          anileridine 0
                                          benazepril 1
                                          benazolin-ethyl 0
                                          benfuracarb 0
                                          chlorimuron-ethyl 0
                                          cilazapril + 0
                                          cinidon ethyl 0
                                          clofibrate 27
                                          coumarin 504 0
                                          diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate + 18
                                          diethyl 2-[(dimethoxyphosphoryl)thio]succinate + 0
                                          diethyl 2-methyl-3-hydroxysuccinate + 0
                                          diethyl 2-methyl-3-oxosuccinate 0
                                          diethyl 2-sulfanylbutanedioate + 18
                                          diethyl maleate 1
                                          diethyl phthalate 0
                                          diphenoxylate + 0
                                          epyrifenacil 0
                                          erythromycin ethylsuccinate 0
                                          etazolate 0
                                          ethyl (2E,4S)-4-[((2R)-2-\{[N-(tert-butoxycarbonyl)-L-valyl]amino\}-2-phenylethanoyl)amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate 0
                                          ethyl (4R)-4-[((2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-\{[(5-methylisoxazol-3-yl)carbonyl]amino\}-4-oxoheptanoyl)amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pentanoate 0
                                          ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate 0
                                          ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate + 0
                                          ethyl 2-(methylamino)-1-phenylcyclohex-3-ene-1-carboxylate + 0
                                          ethyl 2-[4-(2H-1,4-benzothiazin-3-yl)piperazin-1-yl]-1,3-thiazole-4-carboxylate 0
                                          ethyl 2-[5-benzyloxy-4'-(trifluoromethyl)biphenyl-3-yl]pentanoate 0
                                          ethyl 2-[5-hydroxy-4'-(trifluoromethyl)biphenyl-3-yl]pentanoate 0
                                          ethyl 2-\{4-[(6-chloroquinoxalin-2-yl)oxy]phenoxy\}propanoate + 0
                                          ethyl 2-amino-4-hydroxypyrimidine-5-carboxylate 0
                                          ethyl 2-chloro-3-\{2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl]-4-fluorophenyl\}propanoate + 0
                                          ethyl 2-cyanoacetoacetate 0
                                          ethyl 2-cyanopropionate 0
                                          ethyl 2-hydroxy-5-methylpyrazolo[1,5-a]pyrimidine-6-carboxylate + 0
                                          ethyl 2-hydroxypropanoate + 0
                                          ethyl 3,4-dihydroxybenzoate 0
                                          ethyl 3-(2-furyl)acrylate + 0
                                          ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate + 0
                                          ethyl 3-phenyl-2-\{[4-(toluene-4-sulfonyl)thiomorpholine-3-carbonyl]amino\}propionate 0
                                          ethyl 4-(3-hydroxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate + 0
                                          ethyl 4-(3-methoxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate 0
                                          ethyl 4-hydroxybenzoate sulfate 0
                                          ethyl 4-oxocyclohexanecarboxylate 0
                                          ethyl L-phenylalaninate 0
                                          ethyl L-tyrosinate 0
                                          ethyl N-acetyl-L-tyrosinate 0
                                          ethyl N-acetylneuraminate 0
                                          ethyl N-benzoyl-L-tyrosinate 0
                                          ethyl [5-benzyloxy-4'-(trifluoromethyl)biphenyl-3-yl]acetate 0
                                          ethyl acetate 0
                                          ethyl acetoacetate 0
                                          ethyl benzoate 0
                                          ethyl cyclohexanecarboxylate 0
                                          ethyl formate 0
                                          ethyl glyoxylate 0
                                          ethyl hydroxy(phenyl)acetate + 0
                                          ethyl lansiolate 0
                                          ethyl phenylcyanoacetate 0
                                          ethyl phenylglyoxylate 0
                                          ethyl propiolate 0
                                          ethyl trans-caffeate 0
                                          ethylparaben 0
                                          etomidate 0
                                          etretinate 0
                                          fatty acid ethyl ester + 0
                                          felodipine 0
                                          ferrostatin-1 + 0
                                          flufenpyr-ethyl 0
                                          flumazenil 0
                                          hydroprene + 0
                                          imidapril + 0
                                          isoxadifen-ethyl 0
                                          lansic acid 3-ethyl ester 0
                                          loratadine 0
                                          molsidomine 0
                                          monoethyl phthalate 0
                                          nemadipine-A 0
                                          nitrendipine 0
                                          parbenate 0
                                          perindopril 0
                                          pethidine 0
                                          phenthoate 0
                                          pyraflufen-ethyl 0
                                          pyrazophos 0
                                          quinapril 0
                                          ramipril 0
                                          spirapril 0
                                          tazarotene 0
                                          tensyuic acid C 0
                                          tensyuic acid F 0
                                          trandolapril 0
                                          triazamate 0
                                          trinexapac-ethyl 0
                                          ximelagatran 0
                                          ximelagatran (hydroxylamine form) 0
paths to the root